PALANTIR TECHNOLOGIES INC-A (PTX.DE) Fundamental Analysis & Valuation

FRA:PTX • US69608A1088

Current stock price

127.98 EUR
-0.92 (-0.71%)
Last:

This PTX.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. PTX.DE Profitability Analysis

1.1 Basic Checks

  • In the past year PTX was profitable.
  • In the past year PTX had a positive cash flow from operations.
  • In multiple years PTX reported negative net income over the last 5 years.
  • In the past 5 years PTX always reported a positive cash flow from operatings.
PTX.DE Yearly Net Income VS EBIT VS OCF VS FCFPTX.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 18.26%, PTX belongs to the top of the industry, outperforming 92.44% of the companies in the same industry.
  • With a decent Return On Equity value of 22.00%, PTX is doing good in the industry, outperforming 79.83% of the companies in the same industry.
  • PTX has a better Return On Invested Capital (12.89%) than 77.31% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for PTX is significantly below the industry average of 13.78%.
  • The last Return On Invested Capital (12.89%) for PTX is above the 3 year average (6.40%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 18.26%
ROE 22%
ROIC 12.89%
ROA(3y)10.06%
ROA(5y)0.67%
ROE(3y)12.42%
ROE(5y)0%
ROIC(3y)6.4%
ROIC(5y)N/A
PTX.DE Yearly ROA, ROE, ROICPTX.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300 -400

1.3 Margins

  • PTX has a better Profit Margin (36.31%) than 94.12% of its industry peers.
  • Looking at the Operating Margin, with a value of 31.59%, PTX belongs to the top of the industry, outperforming 89.08% of the companies in the same industry.
  • Looking at the Gross Margin, with a value of 82.37%, PTX is in the better half of the industry, outperforming 72.27% of the companies in the same industry.
  • In the last couple of years the Gross Margin of PTX has grown nicely.
Industry RankSector Rank
OM 31.59%
PM (TTM) 36.31%
GM 82.37%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.59%
GM growth 5Y3.99%
PTX.DE Yearly Profit, Operating, Gross MarginsPTX.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. PTX.DE Health Analysis

2.1 Basic Checks

  • PTX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • PTX has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for PTX has been increased compared to 5 years ago.
  • PTX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PTX.DE Yearly Shares OutstandingPTX.DE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B
PTX.DE Yearly Total Debt VS Total AssetsPTX.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • PTX has an Altman-Z score of 144.81. This indicates that PTX is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of PTX (144.81) is better than 100.00% of its industry peers.
  • PTX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 144.81
ROIC/WACC1.21
WACC10.61%
PTX.DE Yearly LT Debt VS Equity VS FCFPTX.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

2.3 Liquidity

  • A Current Ratio of 7.11 indicates that PTX has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 7.11, PTX belongs to the best of the industry, outperforming 92.44% of the companies in the same industry.
  • PTX has a Quick Ratio of 7.11. This indicates that PTX is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 7.11, PTX belongs to the top of the industry, outperforming 92.44% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.11
Quick Ratio 7.11
PTX.DE Yearly Current Assets VS Current LiabilitesPTX.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

10

3. PTX.DE Growth Analysis

3.1 Past

  • PTX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 82.93%, which is quite impressive.
  • Measured over the past years, PTX shows a very strong growth in Earnings Per Share. The EPS has been growing by 132.08% on average per year.
  • Looking at the last year, PTX shows a very strong growth in Revenue. The Revenue has grown by 56.18%.
  • Measured over the past years, PTX shows a very strong growth in Revenue. The Revenue has been growing by 32.58% on average per year.
EPS 1Y (TTM)82.93%
EPS 3Y132.08%
EPS 5YN/A
EPS Q2Q%78.57%
Revenue 1Y (TTM)56.18%
Revenue growth 3Y32.92%
Revenue growth 5Y32.58%
Sales Q2Q%70%

3.2 Future

  • The Earnings Per Share is expected to grow by 53.40% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 49.23% on average over the next years. This is a very strong growth
EPS Next Y78.6%
EPS Next 2Y58.65%
EPS Next 3Y52.95%
EPS Next 5Y53.4%
Revenue Next Year65.23%
Revenue Next 2Y53.37%
Revenue Next 3Y49.58%
Revenue Next 5Y49.23%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PTX.DE Yearly Revenue VS EstimatesPTX.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 10B 20B 30B 40B 50B
PTX.DE Yearly EPS VS EstimatesPTX.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

1

4. PTX.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • PTX is valuated quite expensively with a Price/Earnings ratio of 199.97.
  • Based on the Price/Earnings ratio, PTX is valued a bit more expensive than 60.50% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of PTX to the average of the S&P500 Index (27.50), we can say PTX is valued expensively.
  • A Price/Forward Earnings ratio of 112.10 indicates a quite expensive valuation of PTX.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of PTX indicates a slightly more expensive valuation: PTX is more expensive than 66.39% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 22.62. PTX is valued rather expensively when compared to this.
Industry RankSector Rank
PE 199.97
Fwd PE 112.1
PTX.DE Price Earnings VS Forward Price EarningsPTX.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

  • PTX's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. PTX is more expensive than 64.71% of the companies in the same industry.
  • PTX's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. PTX is more expensive than 61.34% of the companies in the same industry.
Industry RankSector Rank
P/FCF 170.89
EV/EBITDA 242.08
PTX.DE Per share dataPTX.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The decent profitability rating of PTX may justify a higher PE ratio.
  • PTX's earnings are expected to grow with 52.95% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.54
PEG (5Y)N/A
EPS Next 2Y58.65%
EPS Next 3Y52.95%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PTX.DE Dividend Analysis

5.1 Amount

  • No dividends for PTX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PTX.DE Fundamentals: All Metrics, Ratios and Statistics

PALANTIR TECHNOLOGIES INC-A

FRA:PTX (4/23/2026, 2:47:50 PM)

127.98

-0.92 (-0.71%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-02
Earnings (Next)05-04
Inst Owners61.44%
Inst Owner ChangeN/A
Ins Owners3.53%
Ins Owner ChangeN/A
Market Cap305.96B
Revenue(TTM)4.48B
Net Income(TTM)1.63B
Analysts76.67
Price Target165.78 (29.54%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.36%
Min EPS beat(2)6.45%
Max EPS beat(2)22.26%
EPS beat(4)3
Avg EPS beat(4)10.5%
Min EPS beat(4)-0.58%
Max EPS beat(4)22.26%
EPS beat(8)7
Avg EPS beat(8)10.39%
EPS beat(12)10
Avg EPS beat(12)10.73%
EPS beat(16)11
Avg EPS beat(16)-2.66%
Revenue beat(2)2
Avg Revenue beat(2)5.12%
Min Revenue beat(2)4.21%
Max Revenue beat(2)6.02%
Revenue beat(4)4
Avg Revenue beat(4)3.84%
Min Revenue beat(4)0.43%
Max Revenue beat(4)6.02%
Revenue beat(8)7
Avg Revenue beat(8)2.81%
Revenue beat(12)8
Avg Revenue beat(12)1.65%
Revenue beat(16)8
Avg Revenue beat(16)0.99%
PT rev (1m)1.18%
PT rev (3m)1.55%
EPS NQ rev (1m)-0.16%
EPS NQ rev (3m)35.63%
EPS NY rev (1m)-0.03%
EPS NY rev (3m)30.09%
Revenue NQ rev (1m)0.13%
Revenue NQ rev (3m)16.98%
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)17.09%
Valuation
Industry RankSector Rank
PE 199.97
Fwd PE 112.1
P/S 80.21
P/FCF 170.89
P/OCF 168.18
P/B 48.59
P/tB 48.59
EV/EBITDA 242.08
EPS(TTM)0.64
EY0.5%
EPS(NY)1.14
Fwd EY0.89%
FCF(TTM)0.75
FCFY0.59%
OCF(TTM)0.76
OCFY0.59%
SpS1.6
BVpS2.63
TBVpS2.63
PEG (NY)2.54
PEG (5Y)N/A
Graham Number6.15827 (-95.19%)
Profitability
Industry RankSector Rank
ROA 18.26%
ROE 22%
ROCE 18.3%
ROIC 12.89%
ROICexc 181.73%
ROICexgc 181.73%
OM 31.59%
PM (TTM) 36.31%
GM 82.37%
FCFM 46.94%
ROA(3y)10.06%
ROA(5y)0.67%
ROE(3y)12.42%
ROE(5y)0%
ROIC(3y)6.4%
ROIC(5y)N/A
ROICexc(3y)151.52%
ROICexc(5y)N/A
ROICexgc(3y)172.69%
ROICexgc(5y)N/A
ROCE(3y)9.1%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.59%
GM growth 5Y3.99%
F-Score8
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 129.59%
Cap/Sales 0.76%
Interest Coverage 250
Cash Conversion 148.21%
Profit Quality 129.26%
Current Ratio 7.11
Quick Ratio 7.11
Altman-Z 144.81
F-Score8
WACC10.61%
ROIC/WACC1.21
Cap/Depr(3y)71.63%
Cap/Depr(5y)95.48%
Cap/Sales(3y)0.63%
Cap/Sales(5y)0.96%
Profit Quality(3y)236.13%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)82.93%
EPS 3Y132.08%
EPS 5YN/A
EPS Q2Q%78.57%
EPS Next Y78.6%
EPS Next 2Y58.65%
EPS Next 3Y52.95%
EPS Next 5Y53.4%
Revenue 1Y (TTM)56.18%
Revenue growth 3Y32.92%
Revenue growth 5Y32.58%
Sales Q2Q%70%
Revenue Next Year65.23%
Revenue Next 2Y53.37%
Revenue Next 3Y49.58%
Revenue Next 5Y49.23%
EBIT growth 1Y355.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year91.32%
EBIT Next 3Y59.77%
EBIT Next 5Y2.83%
FCF growth 1Y84.06%
FCF growth 3Y125.29%
FCF growth 5YN/A
OCF growth 1Y84.98%
OCF growth 3Y112.09%
OCF growth 5YN/A

PALANTIR TECHNOLOGIES INC-A / PTX.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of PALANTIR TECHNOLOGIES INC-A (PTX.DE) stock?

ChartMill assigns a fundamental rating of 7 / 10 to PTX.DE.


What is the valuation status for PTX stock?

ChartMill assigns a valuation rating of 2 / 10 to PALANTIR TECHNOLOGIES INC-A (PTX.DE). This can be considered as Overvalued.


Can you provide the profitability details for PALANTIR TECHNOLOGIES INC-A?

PALANTIR TECHNOLOGIES INC-A (PTX.DE) has a profitability rating of 7 / 10.


What are the PE and PB ratios of PALANTIR TECHNOLOGIES INC-A (PTX.DE) stock?

The Price/Earnings (PE) ratio for PALANTIR TECHNOLOGIES INC-A (PTX.DE) is 199.97 and the Price/Book (PB) ratio is 48.59.


What is the earnings growth outlook for PALANTIR TECHNOLOGIES INC-A?

The Earnings per Share (EPS) of PALANTIR TECHNOLOGIES INC-A (PTX.DE) is expected to grow by 78.6% in the next year.